Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS

7.51 Jun 18, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 2,373   1,936   1,485   21,977  
Cost of Revenue2,118  832  1,396  652  
Gross Profit 255   1,104   89   21,325  
Operating Expenses
Research Development14,008  13,947  11,619  14,076  
Selling General and Administrative7,251  7,263  7,392  5,216  
Non Recurring -   -   -   -  
Others -  174  168  173  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (21,004) (20,280) (19,090) 1,860  
Income from Continuing Operations
Total Other Income/Expenses Net3,915  796  5,373  (21,470)
Earnings Before Interest And Taxes(17,089)(19,484)(13,717)(19,610)
Interest Expense1,787  1,796  1,804  2,489  
Income Before Tax(18,876)(21,280)(15,521)(22,099)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(18,876)(21,280)(15,521)(26,767)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (18,876) (21,280) (15,521) (22,099)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (18,876) (21,280) (15,521) (22,099)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.